The linked FDA records identify Guangdong Newdermo Biotech Co., Ltd. as the applicant on two premarket notifications for LED light therapy masks, both decided as substantially equivalent in 2026. One record covers eight 4D Glow Mask model designations under product code OHS; the other covers the LED Face Mask Pulse (FAC06NA) under product code NFO, with OHS and OLP listed as subsequent product codes. The two filings sit in different review panels, which separates their regulatory scope even though both name LED mask devices. [1][2][4][6]
The 4D Glow Mask filing
K262781 names the LED Light Therapy Mask in eight model designations: 4D Glow Mask FM19-0K, FM19-1K, FM19-2K, FM19-VK, FM35-0K, FM35-1K, FM35-2K and FM35-VK. The record lists product code OHS, regulation number 878.4810, device class 2, and the advisory committee description General, Plastic Surgery. The application was received on August 6, 2026, and decided substantially equivalent on November 4, 2026, as a Traditional submission not reviewed by a third party, with a summary statement. [1][7]
The LED Face Mask Pulse filing
K261370 covers the LED Light Therapy Masks identified as LED Face Mask Pulse (FAC06NA). The FDA database entry lists product code NFO with subsequent product codes OHS and OLP, regulation number 882.5890, the Neurology review panel, and a Traditional submission not reviewed by a third party. The record shows a receipt date of April 27, 2026, and a substantially equivalent decision on September 16, 2026. The clearance letter for K261370 carries the same device name and lists product codes NFO, OHS and OLP. [2][4][6]
The K261370 clearance letter states that the subject device is as safe, as effective, and performs as well as or better than the legally marketed predicate devices it identifies as K243587, K220198, K214103, K230042, K240360, K230293 and K252146. That statement is the agency's clearance conclusion for this filing, not a measured clinical result. [4]
Applicant identity and published company details
Both FDA records give the applicant address as Bldg. 70(C28), # 9 Huateng Rd., Jinshan Village, Shiqi Town, postal code 511450, country code CN. The K261370 clearance letter gives the same building and street detail with Panyu District, Guangzhou, Guangdong 511450, China, and addresses the letter to JunYi Xing, Certificate Engineer. These are filing addresses; the sources do not establish a corporate headquarters. [1][2][4]
The company's own website, published by NEWDERMO, states that Guangdong Newdermo Biotech Co., Ltd. was established in 2015 as a national high-tech enterprise working in smart home beauty and medical devices, and that it holds more than 180 intellectual property rights and certifications including FDA, ISO13485 and MDSAP. The same page lists 26 invention patents and a contact address at Building C28, Huachuang Industrial Park Jinshan Avenue, Shiji Town, Panyu District, Guangzhou 511450. These are company-published claims; the linked FDA records do not verify the certification or patent counts. [10]
What the filing record does and does not show
The supplied portfolio snapshot links two 510(k) records, both decided SESE, and the smaller record sample contains the same two entries. Those counts describe the supplied filings as of the snapshot date, not total company sales, total portfolio or safety performance. No recall records appear in the supplied sample. [1][2]
A third-party device index lists the 4D Glow Mask record under the General, Plastic Surgery hierarchy at 21 CFR 878.4810 and product code OHS, consistent with the FDA entry. A separate aggregator page describes the K262781 decision as covering eight LED light therapy masks by Guangdong Newdermo Biotech Co., Ltd., with a decision date of November 4, 2026. Neither page adds device performance data. [7][8]



